HIGHLIGHTS
- who: Marta Ávalos-Moreno and collaborators from the GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Department of Legal Medicine, School of Medicine-PTS-University of Granada, Granada, Spain have published the Article: Drug Repurposing for Triple-Negative Breast Cancer, in the Journal: (JOURNAL)
- what: The authors propose a novel and inclusive classification of those approaches whereby drug repurposing can be achieved in silico: structure-based transcriptional signatures-based biological networks-based and data-mining-based drug repositioning.
SUMMARY
Breast cancer is the second most common . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.